What is Arabinogalactan?

Arabinogalactan (AG) is a long-chain, highly branched polysaccharide composed primarily of galactose and arabinose units, most commercially sourced from the Western larch tree (Larix occidentalis). It is classified as a dietary fiber and has been granted GRAS (Generally Recognized As Safe) status by the U.S. FDA. Beyond its role as a functional fiber, arabinogalactan has garnered research interest for its immunomodulatory properties.

How does Arabinogalactan work?

Arabinogalactan acts as a prebiotic, selectively fermenting in the colon to increase populations of beneficial bacteria such as Lactobacillus and Bifidobacterium species, while also elevating short-chain fatty acid (SCFA) production, particularly butyrate. It also appears to interact directly with immune cells—including macrophages and natural killer (NK) cells—via pattern recognition receptors, potentially enhancing innate immune responses. These dual gut-microbiome and direct immunostimulatory mechanisms are thought to underlie its reported benefits.

What forms does Arabinogalactan come in?

Arabinogalactan is most commonly sold as a tasteless, readily soluble powder that can be mixed into beverages or foods, making it one of the more versatile supplement formats. Capsule and tablet forms are also available for standardized dosing. It is also used as a food additive and emulsifier (E409) in some food products.

Where it comes from:

Larch arabinogalactan has a long history of use in traditional medicine among North American indigenous populations, who used larch preparations for wound healing and respiratory support. Modern commercial extraction and clinical investigation began in the 1990s, with the FDA GRAS designation for larch AG granted in 1999.

What does Arabinogalactan help with?

• Immune system support: Arabinogalactan is believed to stimulate innate immunity by activating macrophages and natural killer (NK) cells through interaction with pattern recognition receptors, potentially increasing production of cytokines such as TNF-alpha and interferon-gamma. A randomized, double-blind, placebo-controlled trial by Dion et al. (2016, Nutrients, n=199) found that larch arabinogalactan supplementation (4.5 g/day for 12 weeks) significantly increased NK cell cytotoxicity compared to placebo. This immunostimulatory activity is thought to complement its prebiotic effects by supporting gut-associated lymphoid tissue (GALT).
• Upper respiratory tract infections: Several small to moderate-sized RCTs have investigated arabinogalactan for reducing the incidence and duration of upper respiratory tract infections (URTIs). A double-blind, placebo-controlled trial by Riede et al. (2013, Complementary Medicine Research, n=199) reported that children supplemented with larch AG had fewer cold episodes over a 12-week period compared to placebo. The proposed mechanism involves enhanced mucosal immunity and increased NK cell activity reducing susceptibility to viral respiratory pathogens.
• Gut microbiome imbalance (dysbiosis): As a fermentable dietary fiber, arabinogalactan selectively supports the growth of beneficial colonic bacteria, particularly Bifidobacterium longum and Lactobacillus species, while increasing SCFA production including butyrate and propionate. A controlled human study by Holscher et al. (2015, Journal of Nutrition, n=29) demonstrated that larch AG supplementation significantly increased Bifidobacterium abundance and fecal butyrate concentrations compared to a non-fermentable fiber control. These shifts in microbiome composition are associated with improved gut barrier integrity and reduced intestinal permeability.
• Common cold frequency and severity: Some clinical evidence suggests arabinogalactan may modestly reduce the frequency of common colds in adults and children. The immunomodulatory and prebiotic mechanisms are both proposed as contributing factors, since gut microbiome composition is increasingly recognized as a determinant of systemic antiviral immune readiness. Evidence is promising but based on a limited number of trials with moderate sample sizes, and findings are not entirely consistent across studies.

What can Arabinogalactan help prevent?

• Recurrent upper respiratory tract infections (limited RCT evidence, primarily in pediatric populations)

Which foods are rich in Arabinogalactan?

1. Garlic
2. Jerusalem artichoke
3. Onions
4. Oats
5. Fermented foods (yogurt, kefir, kimchi)

What are the side effects of Arabinogalactan?

• Bloating and flatulence (most common, particularly at doses above 10 g/day)
• Loose stools or mild diarrhea at higher doses
• Mild abdominal cramping (uncommon)
• Theoretical risk of immune overstimulation in individuals with autoimmune conditions (no confirmed clinical cases reported)

Good to know:

Larch arabinogalactan has a well-established safety profile and is FDA GRAS-designated. Clinical trials at doses up to 30 g/day have not identified serious adverse events. Mild gastrointestinal effects are the primary concern and are dose-dependent.

How much Arabinogalactan should you take?

• Recommended daily: 4.5–15 g/day in divided doses for immune support; prebiotic effects studied at 6–30 g/day. Most clinical trials used 4.5–10 g/day as a practical, well-tolerated range.
• Best time of day: No specific timing requirement; can be taken at any time of day. Some practitioners recommend spreading doses across meals to minimize GI discomfort.
• With or without food: Can be taken with or without food; mixing into beverages or food may improve tolerability and palatability.
• Time to effect: Prebiotic/gut microbiome shifts may begin within 1–2 weeks; immune modulation effects generally require 4–8 weeks of consistent supplementation.
• How long to take it: Safe for continuous use; most trials lasted 8–12 weeks. Long-term daily use appears safe based on available data, but periodic evaluation is reasonable. No established cycling protocol.